肿瘤坏死因子相关凋亡诱导配体(TRAIL)受体的表达及TRAIL的抗癌作用
被引量：1
出处
《中华内科杂志》
CAS
CSCD
北大核心
2004年第12期935-936,共2页
Chinese Journal of Internal Medicine
基金
广西壮族自治区卫生厅资助项目 (2 0 0 410 1)
参考文献4
-
1Frese S, Brunner T, Gugger M, et al.Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of c
-
2Ashkenazi A, Dixit VM.Death receptors: signaling and modulation.Science,1998,281:1305-1308.
-
3McDonald ER 3rd, Chui PC, Martelli PF,et al.Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling.J Biol Chem,2001,276:14939-14945.
-
4Fisher MJ, Virmani AK, Wu L,et al.Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.Clin Cancer Res,2001,7:1688-1697.
同被引文献6
-
1KRUYT F A.TRAIL and cancer therapy[J].Cancer Lett,2008,263:14-25.
-
2ZHANG L,FANG B.Mechanisms of resistance to TRAIL-induced apoptotisis in cancer[J].Gene Ther,2005,12(3):228-237.
-
3KI M KIM,YONG J LEE.Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kins and phosphatases associated with the P13K-Akt pathway[J].Oncogene,2005,24(22):355-366.
-
4WANG J H,HUANG QK,CHEN M X.The role of NF-κB in heap-tocellular carcinoma cell[J].Chin Med J,2003,116(5):747.
-
5YU H G,Y U L L,YANG Y,et al.Increased exp ression ofRelA /nuclear factor2 kappa B protein correlates with color-ectal tumorigenesis[J].Ontology,2003,65 (1):37.
-
6NAIR A,VENKATRAMAN M,MALIEKAL T T,et al.NF-κB isconstitutively activated in high grade squamous intraep ithe-lial lesions and squamoua cell carcinomas of the human uterine cervix[J].Oncogene,2003,22 (1):50.
-
1程文芳,易粹琼.肿瘤坏死因子相关凋亡诱导配体诱导胃癌细胞凋亡的研究[J].胃肠病学,2001,6(C00):69-69.
-
2段永亮,王欣,李占飞,邹声泉.TRAIL抑制胆管癌细胞作用的研究[J].中华肝胆外科杂志,2003,9(12):728-728. 被引量：3
-
3金军,赵健,李博华,张霞,张瑞萍,李晓东,钱卫珠,郭亚军.Smac在TRAIL诱导人骨肉瘤Saos-2细胞凋亡中的作用[J].第二军医大学学报,2004,25(1):87-89. 被引量：1
-
4魏晓超,蔺新力,王新娟.肿瘤坏死因子相关的凋亡诱导配体及其与肿瘤治疗前景[J].生理科学进展,2001,32(1):18-22. 被引量：6
-
5李春英,高天文.TNF相关的凋亡诱导配体及其受体与恶性黑素瘤的凋亡[J].中国皮肤性病学杂志,2003,17(4):279-281.
-
6戴维,林木生.肿瘤坏死因子相关凋亡诱导配体及其受体与肝肿瘤[J].广东医学院学报,2004,22(2):186-188. 被引量：1
-
7程宏,祝瑾,贾筱琴.TRAIL与5-FU联合诱导白血病细胞凋亡的分子机理研究[J].扬州大学学报（农业与生命科学版）,2005,26(4):12-15. 被引量：3
-
8薛胜利,冯作化,张桂梅,黎培员,王洪涛,肖徽.鼠源TRAIL真核表达质粒的构建及其抑瘤效应的初步观察[J].华中科技大学学报（医学版）,2002,31(6):618-620. 被引量：1
-
9常卫红.TRAIL与肿瘤治疗[J].中国肿瘤生物治疗杂志,2001,8(2):157-159. 被引量：3
-
10张文荟,张茵,马保根,时杰,陈玉清,孙恺.急性髓系白血病与慢性髓性白血病患者TRAILmRNA表达水平的差异及意义[J].中华血液学杂志,2013,34(2):166-168.
